Regeneron Pharmaceuticals IncOctober 18, 2019

FDA 483 - Regeneron Pharmaceuticals Inc - October 18, 2019

View on Dashboard

Discuss this record with AI

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Regeneron Pharmaceuticals Inc

Record Details

Regeneron Pharmaceuticals Inc, a biological drug substance manufacturer in Rensselaer, NY, was inspected from October 9-18, 2019. The inspection revealed that the firm's quality control unit failed to fully follow its responsibilities and procedures, specifically by not assessing unexpected events that could affect product safety, purity, or potency for regulatory reporting. This indicates a significant lapse in the firm's quality system regarding deviation management and regulatory compliance.

Company: Regeneron Pharmaceuticals Inc
Inspection Date: October 18, 2019
Product Type: Biologics
Office: Division of Human and Animal Food Operations - East I
People: Sony Mathews (Consumer Safety Officer Drug Specialist)
Mindy M. Chou
Patric C. Klotzbuecher

Open in Dashboard

ID · cdc34046-95b0-4b53-851f-dfbbdefa15ff